-
NHS head and neck cancer patients barred from Opdivo
pharmatimes
April 12, 2017
Cost regulators have ruled that Bristol-Myers Squibb’s immunotherapy Opdivo is too expensive for NHS use to treat head ...
-
FDA approves first two antiviral hep C drugs for paediatric patients
pharmafile
April 11, 2017
The FDA has given the go-ahead for two hepatitis C treatments for use in young and adolescent patients: Sovaldi ...
-
PhRMA Launches New "Share the Savings" Campaign to Urge Payers to Share Negotiated Discounts with Pa
americanpharmaceuticalreview
April 07, 2017
The Pharmaceutical Research and Manufacturers of America (PhRMA) has unveiled "Share the Savings," a new campaign to educate the public about the lack of rebate pass-through for commercially insured patients with high deductibles and coinsurance.
-
Patients call for halt to NICE changes
pharmatimes
March 29, 2017
A coalition of almost 200 patient groups representing families affected by rare and genetic conditions have called for a halt to planned changes in the way therapies are appraised for NHS...
-
Finding Solutions For Patients
lilly
March 21, 2017
This article comes from Dave Ricks, President and CEO
-
Rare disease patients in UK wait average of two years for medications
pharmaceutical-technology
March 16, 2017
A new report published by Irish biotechnology company Shire has shown that rare disease patients in England...
-
Barriers to Integrated Care and How to Overcome Them
lilly
February 28, 2017
Today’s blog is written by Thomas Allvin, Director for Healthcare Systems at the European Federation of Pharmaceutical Industries and Associations (EFPIA).